Relation Therapeutics expands GSK AI drug discovery deal worth up to $110M
anshulkundaje · x · 2026-07-31
AI biotech firm Relation Therapeutics announced an expanded collaboration with pharmaceutical giant GSK. The partnership will deploy Relation's flagship cellular foundation model, MORGAN, at a new scale. The deal includes upfront and success-based milestone payments totaling up to $110 million.
Related event: Relation and GSK Expand AI Drug Discovery Partnership to $110M(2 posts)→
More from Companies & People
- Engineers credited for Tesla's demo-night downforce fan and thruster integration — MatthewChang · 2026-10-16
- BotsCrew shares how company-wide Claude setup saves 2+ hours per sales proposal — max_gladysh · 2026-10-16
- Replit CEO Amjad Masad Says the Future of Work Is the 'Self-Driving Company' — TechCrunch AI · 2026-10-16
- React veteran Eli White joins Meta Superintelligence Labs after a decade on React — Vjeux · 2026-10-16
- How the latest AI model jump is disrupting SaaS and game studio business models — The AI Daily Brief · 2026-10-16
- Joanna Shields named to 2026 Responsible Tech Guide, warns of AI adaptation gap — joannashields · 2026-10-16